Atrial fibrillation is present, but the R-to-R interval has become regular
15
Digoxin is a cardiac glycoside indicated for the treatment of chronic heart failure and persistent atrial fibrillation
99; 95% confidence interval [CI], 0
[] The elimination half life may be as high as 61–170 hours in premature neonates
This may be misinterpreted as a therapeutic failure and worsening toxicity
Please refer to the Limitations or Utilization Guidelines section on previous page(s) for frequency information
Introduction
) • Digoxin :naturally occurring drug • Digoxin: primary cardiac glycoside in clinical use • Main Clinical Indications: • Heart Failure • Increases cardiac output by (+) inotropic actions Therapeutic level of 0
Increased awareness of this risk on the use of digoxin in the treatment of patients with HF implanted with devices is warranted
Target concentration levels 3
to help document whether drug therapy is effective in reducing these symptoms
g
2) Potassium of over 5 mEq/L in acute ingestions